Clinical feasibility of Gd-EOB-DTPA-enhanced MR imaging for assessing liver function: validation with ICG tests and parenchymal cell volume

Clin Imaging. 2016 Jul-Aug;40(4):797-800. doi: 10.1016/j.clinimag.2016.03.003. Epub 2016 Mar 9.

Abstract

Objective: Using Gd-EOB-DTPA-enhanced MRI to assess liver function and validate with indocyanine green (ICG) tests and parenchymal cell volume (PCV).

Methods: Nineteen patients scheduled for operation were enrolled. Functional liver volume (FLV) was computed from 20min post-contrast images. ICG retention was measured in serum 15min after injection. The histological PCV was determined from resected liver specimen.

Results: FLV showed significantly correlated with ICG retention (ICG-R15: r=-0.47, P=.042) and PCV (r=0.814, P<.001).

Conclusions: Gd-EOB-DTPA-enhanced MRI is clinically feasible for quantifying liver function.

Keywords: Gd-EOB-DTPA; chronic liver disease; indocyanine green; liver fibrosis; magnetic resonance imaging.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Cell Size
  • Contrast Media*
  • Feasibility Studies
  • Female
  • Gadolinium DTPA*
  • Humans
  • Image Enhancement / methods*
  • Indocyanine Green*
  • Liver / diagnostic imaging
  • Liver / pathology*
  • Liver / physiopathology
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Reproducibility of Results

Substances

  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Indocyanine Green
  • Gadolinium DTPA